HCPCS Codes Similar to Q0235

HCPCS Codes Similar to “Q0235” Code.
Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg

M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0237 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
M0249 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON	M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
Q0237 Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	Q0249 Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
S9538 Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON	G9839 Anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9844 Patient did not receive anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9845 Patient received anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
S9562 Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20030101 Code effective date: 20230401 TXT \| PDF \| XML \| JSON	G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) Code added date: 20140602 Code effective date: 20160101 TXT \| PDF \| XML \| JSON

M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
M0237 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
M0249 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON	M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
Q0237 Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON	Q0249 Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON
S9538 Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem Code added date: 20020101 Code effective date: 20020101 TXT \| PDF \| XML \| JSON	G9839 Anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9844 Patient did not receive anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9845 Patient received anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
S9562 Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20030101 Code effective date: 20230401 TXT \| PDF \| XML \| JSON	G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) Code added date: 20140602 Code effective date: 20160101 TXT \| PDF \| XML \| JSON